Impact of price deregulation policy on the affordability of essential medicines for women's health: a panel data analysis [0.03%]
价格放开政策对女性健康基本药物可负担性的影响：基于面板数据的分析
Junjie Liu,Liming Wang,Chenxi Liu et al.
Junjie Liu et al.
Background: A new policy which required deregulation on prices of off-patent medicines for women's health during procurement was introduced in China in September 2015. The current study examines this policy's impact on th...
Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe [0.03%]
欧洲乳糜泻克罗恩病生物制剂序贯治疗的成本效用分析
Fanni Rencz,László Gulácsi,Márta Péntek et al.
Fanni Rencz et al.
Background: This study aims to compare the cost-effectiveness of treatment sequences with available biologics, including adalimumab (ADA), biosimilar infliximab (bsIFX), originator infliximab (IFX) and vedolizumab (VEDO) ...
Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications [0.03%]
西格列汀治疗巴西2型糖尿病患者的经济效果及意义分析
Gustavo Laine Araujo De Oliveira,Augusto Afonso Guerra Júnior,Brian Godman et al.
Gustavo Laine Araujo De Oliveira et al.
Vildagliptin is an inhibitor of the enzyme dipeptidyl peptidase 4, indicated for the treatment of type 2 diabetes mellitus, combined or not with metformin. This study aims to evaluate the cost-effectiveness of vildagliptin in the Brazilian ...
Analysis of the implementation of a personalized care model in diabetes mellitus as an example of chronic disease with information and communication technology support [0.03%]
基于信息和通信技术支援的糖尿病个性化护理模式实证研究——以慢性病为例
N López-Martínez,J L Segú,J Vázquez-Castro et al.
N López-Martínez et al.
Diabetes mellitus affects 13.8% of the adult population in Spain, representing some 8.2% of total Spanish health spending, which may be reduced by optimizing treatment and disease monitoring. Areas covered: This perspective article aims to ...
Douglas Mogul,Yusuke Nakamura,Jaein Seo et al.
Douglas Mogul et al.
Celiac disease is an autoimmune disease that results from exposure to gluten in genetically susceptible individuals and leads to a range of gastrointestinal and extraintestinal symptoms. Areas covered: In order to evaluate the literature wi...
Direct and indirect cost of managing alzheimer's disease and related dementias in the United States [0.03%]
美国阿尔茨海默病及相关痴呆症管理的直接和间接成本
Arijita Deb,James Douglas Thornton,Usha Sambamoorthi et al.
Arijita Deb et al.
Care of individuals with Alzheimer's Disease and Related Dementias (ADRD) poses special challenges. As the disease progresses, individuals with ADRD require increasing levels of medical care, caregiver support, and long-term care which can ...
Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling [0.03%]
与晚期非小细胞肺癌相关的效用值：经济学模型的数据需求
Jacqueline Brown,Keziah Cook,Kelly Adamski et al.
Jacqueline Brown et al.
Cost-effectiveness analyses often inform healthcare reimbursement decisions. The preferred measure of effectiveness is the quality adjusted life year (QALY) gained, where the quality of life adjustment is measured in terms of utility. Areas...
Federal procurement of unlicensed medicines in Brazil; findings and implications [0.03%]
巴西政府采购未授权药物；发现与影响分析
Cristiane Roberta Dos Santos Teodoro,Rosângela Caetano,Brian Godman et al.
Cristiane Roberta Dos Santos Teodoro et al.
Background: There are safety concerns with using unlicensed medicines across countries including Brazil. Consequently this needs to be evaluated and concerns address if pertinent. ...
The value of open access and a patient centric approach to oral oncolytic utilization in the treatment of Chronic Myelogenous Leukemia: A U.S. perspective [0.03%]
从美国视角看口服肿瘤溶解药在慢性髓性白血病治疗中采用开放访问和以患者为中心的方法的价值
Lopamudra Das,Matthew Gitlin,Lisa R Siegartel et al.
Lopamudra Das et al.
Since the introduction of tyrosine kinase inhibitors (TKIs), the treatment of patients with chronic myelogenous leukemia (CML) has resulted in significant improvement in patient survival but at a higher pharmaceutical cost to payers. The re...